NCT03162237View on ClinicalTrials.gov

Safety and Efficacy Study of Islets Xenotransplantation

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Type 1 Diabetes
Interventions
OTHER

Porcine islets

"Porcine islets: 10000IEQ/Kg;~Tacrolimus: 0.087mg/kg, Bid;~mycophemo-latemofetil (MMF): 1g x 2/d;~NULOJIX(belatacept): Day 1 (prior to transplantation), Day 5, Week 2, Week 4, Week 8, Week 12 10mg/kg"

OTHER

Autologous Treg

Autologous Treg: 2x10\^6/Kg

Trial Locations (1)

410013

Cell Transplantation and Gene Therapy Institute, Changsha

All Listed Sponsors
collaborator

Hunan Xeno-life Science Ltd

UNKNOWN

lead

Wei Wang,MD

OTHER

NCT03162237 - Safety and Efficacy Study of Islets Xenotransplantation | Biotech Hunter | Biotech Hunter